Kyverna Therapeutics, Inc. ($KYTX)
Filing Information
| Accession Number | 0001193125-26-248435 |
|---|---|
| Form Type | 4 |
| Filing Date | May 29, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
25,675
Total Value
$0.00
P&L
+inf% (+$218,751.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 27, 2026 | Grant/Award | 5,093 | $0.00 | $0.00 | 21,727 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | May 27, 2026 | Grant/Award | 20,582 | $0.00 | $0.00 | 20,582 | Direct | โ | View Details |